Academician Zhang Boli, vice president of China Association for the promotion of drugs won the 2016 Wu Jieping medical award
-
Last Update: 2016-11-25
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Source: from November 24, 2016, Wu Jieping Medical Foundation announced to the public that it would award the 2016 Wu Jieping medical award to academician Zhang Boli for his outstanding contribution to the modernization research and development of Chinese traditional medicine At the same time, the 2016 Wu Jieping pharmaceutical innovation award was announced, which was awarded to Professor Wang Xijun, Professor Liu motherland, Professor Huang Xiaojun and Professor Cai Xiujun respectively, in recognition of the innovative achievements and outstanding contributions made by the four winners in their respective disciplines According to Xiao Meng, President of Wu Jieping medical foundation, the awarding ceremony of 2016 Wu Jieping medical award and medical innovation award will be held in Zhongshan City, Guangdong Province on December 2 Brief introduction of the winners: Zhang Boli (February 1948), expert and professor of internal medicine of traditional Chinese medicine, academician of Chinese Academy of engineering, President of Chinese Academy of Sciences and President of Tianjin University of traditional Chinese medicine Professor Zhang Boli has been engaged in the prevention and treatment of cardiovascular and cerebrovascular diseases and the modernization of traditional Chinese medicine for more than 30 years Led the team to undertake three national "973" projects -- Basic Research on key scientific issues of prescription compatibility Through multi-disciplinary collaborative research, the team developed "component compatibility" The mode and related technical system of developing modern Chinese medicine are established The common technologies of effective component preparation, analysis and activity evaluation are established The methods of base line equiratio increase and decrease, polarity segmented screening and drug pair synergistic effect optimization are established The research and development mode and technical route of component Chinese medicine of "standard component, component effect relationship, component compatibility and optimization design" are established.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.